Literature DB >> 22948566

Selected cytokine profiles during remission in bipolar patients.

Agnieszka Remlinger-Molenda1, Pawel Wojciak, Michal Michalak, Jacek Karczewski, Janusz K Rybakowski.   

Abstract

OBJECTIVES: The aim of the study was to examine the cytokine status in bipolar patients during immediate remission after acute episodes of mania or depression and in patients with sustained (≥6 months) remission, compared with healthy controls.
METHODS: The study was performed on 121 bipolar patients, of whom 35 were in immediate remission after mania, 41 were in immediate remission after depression, and 45 were in >6-month remission on lithium monotherapy or lithium combined with other drugs. The control group consisted of 78 healthy individuals without any history of psychiatric or immunological illnesses. Serum concentrations of IL-1β, IL-2, IL-6, IL-10, TNF-α and IFN-γ were determined using the Human Th1/Th2 Cytometric Bead Array method.
RESULTS: The concentration of IL-10 was higher in patients in remission after mania and the concentration of IFN-γ was higher in those in remission after depression than in healthy controls. On the other hand, cytokine concentrations in patients with sustained remission were not different from those of healthy subjects.
CONCLUSIONS: The results obtained in this study show that sustained remission in bipolar patients achieved mostly by lithium maintenance brings the cytokine status to a level similar to healthy control subjects.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948566     DOI: 10.1159/000339949

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  11 in total

1.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

2.  Inflammatory markers among adolescents and young adults with bipolar spectrum disorders.

Authors:  Benjamin I Goldstein; Francis Lotrich; David A Axelson; Mary Kay Gill; Heather Hower; Tina R Goldstein; Jieyu Fan; Shirley Yen; Rasim Diler; Daniel Dickstein; Michael A Strober; Satish Iyengar; Neal D Ryan; Martin B Keller; Boris Birmaher
Journal:  J Clin Psychiatry       Date:  2015-11       Impact factor: 4.384

Review 3.  Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers.

Authors:  Ather Muneer
Journal:  Psychiatry Investig       Date:  2015-11-20       Impact factor: 2.505

4.  A combined marker of inflammation in individuals with mania.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Crystal Vaughan; Emily Katsafanas; Sunil Khushalani; Robert Yolken
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

Review 5.  Secondary Mania induced by TNF-α inhibitors: A systematic review.

Authors:  Alessandro Miola; Veronica Dal Porto; Nicola Meda; Giulia Perini; Marco Solmi; Fabio Sambataro
Journal:  Psychiatry Clin Neurosci       Date:  2021-11-02       Impact factor: 12.145

Review 6.  The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder.

Authors:  Helena Kyunghee Kim; Wenjun Chen; Ana Cristina Andreazza
Journal:  Neural Plast       Date:  2015-05-13       Impact factor: 3.599

Review 7.  Modulating Neuroinflammation to Treat Neuropsychiatric Disorders.

Authors:  Franziska A Radtke; Gareth Chapman; Jeremy Hall; Yasir A Syed
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

Review 8.  Is Toxoplasma gondii a Trigger of Bipolar Disorder?

Authors:  Claudia Del Grande; Luca Galli; Elisa Schiavi; Liliana Dell'Osso; Fabrizio Bruschi
Journal:  Pathogens       Date:  2017-01-10

Review 9.  Cytokines in bipolar disorder: paving the way for neuroprogression.

Authors:  Izabela Guimarães Barbosa; Moisés Evandro Bauer; Rodrigo Machado-Vieira; Antonio Lucio Teixeira
Journal:  Neural Plast       Date:  2014-09-09       Impact factor: 3.599

Review 10.  Challenging the Negative Perception of Lithium and Optimizing Its Long-Term Administration.

Authors:  Janusz K Rybakowski
Journal:  Front Mol Neurosci       Date:  2018-10-02       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.